Correlation Between ATyr Pharma and Prime Medicine,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Prime Medicine, Common, you can compare the effects of market volatilities on ATyr Pharma and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Prime Medicine,.

Diversification Opportunities for ATyr Pharma and Prime Medicine,

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between ATyr and Prime is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Prime Medicine, go up and down completely randomly.

Pair Corralation between ATyr Pharma and Prime Medicine,

Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the Prime Medicine,. In addition to that, ATyr Pharma is 1.79 times more volatile than Prime Medicine, Common. It trades about -0.04 of its total potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.04 per unit of volatility. If you would invest  806.00  in Prime Medicine, Common on August 27, 2024 and sell it today you would lose (486.00) from holding Prime Medicine, Common or give up 60.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy53.23%
ValuesDaily Returns

ATyr Pharma  vs.  Prime Medicine, Common

 Performance 
       Timeline  
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Prime Medicine, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.

ATyr Pharma and Prime Medicine, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATyr Pharma and Prime Medicine,

The main advantage of trading using opposite ATyr Pharma and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.
The idea behind ATyr Pharma and Prime Medicine, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital